Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : PTP-001
Therapeutic Area : Musculoskeletal
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The study is evaluating the safety and efficacy of MOTYS (PTP-001) to treat osteoarthritis (OA) of the knee. Researchers are enrolling 20 patients with each patient receiving a single injection of PTP-001.
Product Name : MOTYS
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
November 03, 2021
Lead Product(s) : PTP-001
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : PTP-001
Therapeutic Area : Musculoskeletal
Study Phase : Phase II
Sponsor : NBCD
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
October 29, 2021
Lead Product(s) : PTP-001
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II
Sponsor : NBCD
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : PTP-001
Therapeutic Area : Musculoskeletal
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The in vivo activity of PTP‐001 on joint pain and histopathology was evaluated in a rat model of OA that was induced surgically by destabilization of the medial meniscus.
Product Name : MOTYS
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
May 25, 2021
Lead Product(s) : PTP-001
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : PTP-001
Therapeutic Area : Musculoskeletal
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety Study of PTP-001 for Treating Knee Osteoarthritis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
November 17, 2020
Lead Product(s) : PTP-001
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable